Floatz logo

Ricolinostat

Painful Diabetic Peripheral Neuropathy

Regenacy Pharmaceuticals LLCSmall moleculePhase 2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Painful Diabetic Peripheral Neuropathy cohort.

Asset / SponsorPhaseRating
Duloxetine
University of Rochester
Phase 4BB
Pregabalin
Syeda Khatoon e Jannat Welfare Foundation
Phase 4BB
(±)-TRAMADOL
Turku University Hospital
Phase 4BB
Capsaicin
Thammasat University
Phase 2/3B
Adezunap
Apurano Pharmaceuticals GmbH
Phase 3B

View all 20 →

Same molecule, other indications

Ricolinostat is also rated in:

plasma cell myelomaDormant
CCC
Indicative ·
48 / 100
View asset →
lymphoid neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
B-cell chronic lymphocytic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →